Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis

被引:14
作者
Mei, Ying [1 ]
You, Yu [2 ]
Xia, Jin [2 ]
Gong, Jian-Ping [2 ]
Wang, Yun-Bing [2 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Minist Hlth, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 2, Dept Hepatobiliary Surg, 76 Linjiang Rd, Chongqing 400010, Peoples R China
关键词
Cirrhosis; Hepatocellular carcinoma; MicroRNA; Bioinformatic analysis; MESENCHYMAL TRANSITION; INTERACTION NETWORKS; TUMOR-SUPPRESSOR; LIVER; HEPATITIS; CANCER; HCC; PROLIFERATION; SURVEILLANCE; MECHANISMS;
D O I
10.1159/000492254
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/Aims: Few studies have been designed to directly investigate the exact mechanisms underlying the different phenotypes between cirrhotic and non-cirrhotic hepatocellular carcinoma (HCC). This study aimed to illuminate the incidence and developmental mechanisms for both types of HCC through differentially expressed microRNAs (miRNAs) using bioinformatic analysis. Methods: The miRNA-seq data and clinical data of patients (from The Cancer Genome Atlas (TCGA) database) were utilized to determine differentially expressed miRNAs between cirrhotic and non-cirrhotic HCC. Afterwards, the function of the selected miRNAs was predicted with online tools. Furthermore, the miRNA expression and clinical significance were validated by external datasets and our experiment. Results: The present study included 135 non-cirrhotic and 80 cirrhotic patients to find differentially expressed miRNAs. Among them, four miRNAs (mir-1296, mir-23c, mir-149, and mir-95) were finally selected for further validation and analysis. Correlation analysis found that two miRNAs are greatly associated with the non-cirrhotic HCC patients' clinical traits, such as the T, M, and N tumor stages. However, only mir-23c was associated with the cirrhotic HCC patients' tumor T and N stages. Furthermore, survival analysis revealed that increased mir-149 in non-cirrhotic HCC, patients' age and the existence of vessels in the tumor in cirrhotic HCC were independent risk factors for the patients' postoperative overall survival. Functional and interaction analyses also supported the notion that these miRNAs function through some pathways that influence the behavior of the HCC. These results are strongly supported by analysis of extra datasets and our experiment. Conclusions: The cirrhotic and non-cirrhotic HCC types involve differentially expressed miRNAs, which are correlated with distinctive pathological traits. To some extent, non-cirrhotic HCC seems more dependent on miRNA network regulation, but additional studies are needed to confirm this conclusion. (c) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1443 / 1456
页数:14
相关论文
共 52 条
  • [1] Predicting effective microRNA target sites in mammalian mRNAs
    Agarwal, Vikram
    Bell, George W.
    Nam, Jin-Wu
    Bartel, David P.
    [J]. ELIFE, 2015, 4
  • [2] The microRNA.org resource: targets and expression
    Betel, Doron
    Wilson, Manda
    Gabow, Aaron
    Marks, Debora S.
    Sander, Chris
    [J]. NUCLEIC ACIDS RESEARCH, 2008, 36 : D149 - D153
  • [3] Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells
    Bie, Beibei
    Sun, Jin
    Li, Jun
    Guo, Ying
    Jiang, Wei
    Huang, Chen
    Yang, Jun
    Li, Zongfang
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (04) : 1519 - 1531
  • [4] Identification of metastasis-related microRNAs in hepatocellular carcinoma
    Budhu, Anuradha
    Jia, Hu-Liang
    Forgues, Marshonna
    Liu, Chang-Gong
    Goldsteir, David
    Lam, Amy
    Zanetti, Krista A.
    Ye, Qing-Hai
    Qin, Lun-Yju
    Croce, Carlo M.
    Tang, Zhao-You
    Wang, Xin Wei
    [J]. HEPATOLOGY, 2008, 47 (03) : 897 - 907
  • [5] Role of miRNAs in development and disease: Lessons learnt from small organisms
    Chandra, Swati
    Vimal, Divya
    Sharma, Divya
    Rai, Vipin
    Gupta, Subash Chandra
    Chowdhuri, D. Kar
    [J]. LIFE SCIENCES, 2017, 185 : 8 - 14
  • [6] Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
    Chayanupatkul, Maneerat
    Omino, Ronald
    Mittal, Sahil
    Kramer, Jennifer R.
    Richardson, Peter
    Thrift, Aaron P.
    El-Serag, Hashem B.
    Kanwal, Fasiha
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (02) : 355 - 362
  • [7] MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP
    Du, Yang
    Zhu, Heng-cheng
    Liu, Xiu-heng
    Wang, Lei
    Ning, Jin-zhuo
    Xiao, Cheng-cheng
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (03) : 1135 - 1146
  • [8] miRNA-149 promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia
    Fan, Sheng-jin
    Li, Hui-bo
    Cui, Gang
    Kong, Xiao-lin
    Sun, Li-li
    Zhao, Yan-qiu
    Li, Ying-hua
    Zhou, Jin
    [J]. LEUKEMIA RESEARCH, 2016, 41 : 62 - 70
  • [9] Hepatocellular Carcinoma (HCC) A Global Perspective
    Ferenci, Peter
    Fried, Michael
    Labrecque, Douglas
    Bruix, Jordi
    Sherman, Morris
    Omata, Masao
    Heathcote, Jenny
    Piratsivuth, Teehra
    Kew, Mike
    Otegbayo, Jesse A.
    Zheng, S. S.
    Sarin, S.
    Hamid, Saeed S.
    Modawi, Salma Barakat
    Fleig, Wolfgang
    Fedail, Suliman
    Thomson, Alan
    Khan, Aamir
    Malfertheiner, Peter
    Lau, George
    Carillo, Flair J.
    Krabshuis, Justus
    Le Mair, Anton
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) : 239 - 245
  • [10] Fujii Tomomi, 2015, Biochem Biophys Res Commun, V456, P183, DOI 10.1016/j.bbrc.2014.11.056